ASAP — Asarina Pharma AB (publ) Balance Sheet
0.000.00%
Last trade - 00:00- SEK1.09m
- -SEK1.07m
Annual balance sheet for Asarina Pharma AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 130 | 58.5 | 21.7 | 13.6 | 3.16 |
| Net Total Receivables | 8.24 | 7.78 | 7.12 | 1.99 | 2.03 |
| Prepaid Expenses | |||||
| Total Current Assets | 138 | 66.5 | 28.9 | 15.7 | 5.3 |
| Net Property, Plant And Equipment | 1.77 | 1.83 | 1.48 | 1.18 | 0.778 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 140 | 68.3 | 30.4 | 16.9 | 6.08 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.4 | 15.7 | 3.92 | 2.25 | 4.43 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 20.4 | 15.7 | 9.22 | 2.25 | 4.43 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 119 | 52.6 | 21.1 | 14.6 | 1.65 |
| Total Liabilities & Shareholders' Equity | 140 | 68.3 | 30.4 | 16.9 | 6.08 |
| Total Common Shares Outstanding |